CMS Proposal Would Cut Payment for Same-Day Injection Visits
-
By
-
Jim Gallagher, senior managing editor
-
July 15, 2026
-
4 min
By
Jim Gallagher, senior managing editor
July 15, 2026
by Jim Gallagher, senior managing editor
July 15, 2026
Arshad M. Khanani, MD, FASRS, discusses phase 2 findings for OCU410, an investigational gene therapy for geographic atrophy. A phase 3 program is expected to begin later this year.
July 15, 2026
At the ASRS meeting in Montreal, Baruch D. Kuppermann, MD, PhD, presented BRVO findings from the phase 1/2a RIOJA program evaluating the investigational VEGF/Tie2 bispecific.
July 15, 2026
At ASRS 2026, Dilsher S. Dhoot, MD, FASRS, shared additional phase 3 SOL-1 data on vision maintenance, rescue treatment, and safety with investigational OTX-TKI (Axpaxli) in neovascular AMD.
July 15, 2026